FBInvestor
Stocks / Mirati Therapeutics Inc Cvr
Institutional Ownership

Mirati Therapeutics Inc Cvr

CUSIP 604CVR105RIGQ1 2026

Earnings

Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).

Coming soon